Phenotype of spirometric impairment in an aging population

American Journal of Respiratory and Critical Care Medicine

Volumn 193, Issue 7, 2016, Pages 727-735

  Vaz Fragoso, Carlos A ^a,b   McAvay, Gail ^b   Van Ness, Peter H ^b   Casaburi, Richard ^c   Jensen, Robert L ^d   MacIntyre, Neil ^e   Klar Yaggi, H ^a,b   Gill, Thomas M ^b   Concato, John ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Restriction

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; AGING; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG EMPHYSEMA; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; SIX MINUTE WALK TEST; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CLASSIFICATION; COMORBIDITY; COMPLICATION; DIAGNOSTIC IMAGING; EMPHYSEMA; EXERCISE TEST; FORCED EXPIRATORY FLOW; GENETICS; LUNG; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SMOKING; STANDARD; STANDARDS; UNITED STATES; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; AGING; COMORBIDITY; DYSPNEA; EMPHYSEMA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REFERENCE STANDARDS; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84988835453     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201508-1603OC     Document Type: Article

References (50)

1. Vaz Fragoso CA, Gill TM. Respiratory impairment and the aging lung: A novel paradigm for assessing pulmonary function. J Gerontol A Biol Sci Med Sci 2012;67:264-275.
2. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26: 948-968.
3. Hansen JE, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not, 70%. Chest 2007;131:349-355.
4. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, Rosenthal M, Corey M, Lebecque P, Cole TJ. Reference ranges for spirometry across all ages: A new approach. Am J Respir Crit Care Med 2008;177:253-260.
5. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: The global lung function 2012 equations. Eur Respir J 2012;40:1324-1343.
6. World Health Organization (WHO). Good health adds life to years: global brief for World Health Day 2012. Geneva: WHO; April 2012 [accessed 2015 Nov 18]. Available from: http://www. who. int/ageing/ publications/whd2012-global-brief/en/
7. Wan H, Sengupta M, Velkoff VA, DeBarros KA; U. S. Census Bureau. 651 in the United States: 2005 (Current Population Reports: P23-209). Washington, DC: U. S. Government Printing Office; 2005 [accessed 2015 Nov 18]. Available from: http://www. census. gov/ prod/2006pubs/p23-209. pdf
8. Marcus BS, McAvay G, Gill TM, Vaz Fragoso CA. Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons. J Am Geriatr Soc 2015; 63:251-257.
9. Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA 2012;308: 1254-1263.
10. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005;294:716-724.
11. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43.
12. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959;2:257-266.
13. Enright PL, Kronmal RA, Higgins MW, Schenker MB, Haponik EF. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 1994;106:827-834.
14. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116:1632-1637.
15. Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, et al. GOLD 2011 disease severity classification in COPDGene: A prospective cohort study. Lancet Respir Med 2013;1:43-50.
16. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-117.
17. Casanova C, Celli BR, Barria P, Casas A, Cote C, de Torres JP, Jardim J, Lopez MV, Marin JM, Montes de Oca M, et al.; Six Minute Walk Distance Project (ALAT). The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 2011;37:150-156.
18. Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, Senocak H, Alp N. Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J 2007;34:166-169.
19. Cote CG, Casanova C, Marn JM, Lopez MV, Pinto-Plata V, de Oca MM, Dordelly LJ, Nekach H, Celli BR. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 2008;31:571-578.
20. Bhatt SP, Sieren JC, Dransfield MT, Washko GR, Newell JD Jr, Stinson DS, Zamba GK, Hoffman EA; COPDGene Investigators. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax 2014;69:409-414.
21. Grydeland TB, Dirksen A, Coxson HO, Eagan TM, Thorsen E, Pillai SG, Sharma S, Eide GE, Gulsvik A, Bakke PS. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med 2010; 181:353-359.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
23. Allen SC, Yeung P. Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients. Age Ageing 2006;35:304-306.
24. Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease. JAMA Intern Med 2013;173:1175-1185.
25. Pellegrino R, Antonelli A, Mondino M. Bronchodilator testing: An endless story. Eur Respir J 2010;35:952-954.
26. Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma. Int J Chron Obstruct Pulmon Dis 2008;3:693-699.
27. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58:659-664.
28. Vaz Fragoso CA, Concato J, McAvay G, Yaggi HK, Van Ness PH, Gill TM. Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores. J Am Geriatr Soc 2011;59:1847-1854.
29. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Gill TM. Respiratory impairment and COPD hospitalisation in older persons: A competing risk analysis. Eur Respir J 2012;40:37-44.
30. Vaz Fragoso CA, McAvay G, Van Ness PH, Casaburi R, Jensen RL, MacIntyre N, Gill TM, Yaggi HK, Concato J. Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med 2015; 192:817-825.
31. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16: 219-242.
32. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volumereduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
33. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294:1071-1075.
34. Lee HM, Le H, Lee BT, Lopez VA, Wong ND. Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010;36:1002-1006.
35. Nakajima K, Kubouchi Y, Muneyuki T, Ebata M, Eguchi S, Munakata H. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008;134:712-718.
36. van der Palen J, Rea TD, Manolio TA, Lumley T, Newman AB, Tracy RP, Enright PL, Psaty BM. Respiratory muscle strength and the risk of incident cardiovascular events. Thorax 2004;59:1063-1067.
37. Steier J, Lunt A, Hart N, Polkey MI, Moxham J. Observational study of the effect of obesity on lung volumes. Thorax 2014;69:752-759.
38. Di Bari M, Chiarlone M, Matteuzzi D, Zacchei S, Pozzi C, Bellia V, Tarantini F, Pini R, Masotti G, Marchionni N. Thoracic kyphosis and ventilatory dysfunction in unselected older persons: An epidemiological study in Dicomano, Italy. J Am Geriatr Soc 2004; 52: 909-915
39. Sun X-G, Hansen JE, Oudiz RJ, Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003;41: 1028-1035.
40. Hyatt RE, Cowl CT, Bjoraker JA, Scanlon PD. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest 2009;135:419-424.
41. Witte KK, Morice A, Cleland JGF, Clark AL. The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry. J Card Fail 2004;10:149-154.
42. Vestbo J, Hurd SS, Agust AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
43. Vaz Fragoso CA, Gill TM, McAvay G, Quanjer PH, Van Ness PH, Concato J. Respiratory impairment in older persons: when less means more. Am J Med 2013;126:49-57.
44. Miller MR, Pincock AC. Predicted values: how should we use them Thorax 1988;43:265-267.
45. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions. Respir Med 2010;104:1189-1196.
46. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:446-451.
47. Feinstein AR. The inadequacy of binary models for the clinical reality of three-zone diagnostic decisions. J Clin Epidemiol 1990;43:109-113.
48. Gevenois PA, De Vuyst P, de Maertelaer V, Zanen J, Jacobovitz D, Cosio MG, Yernault JC. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996;154:187-192.
49. Smith BM, Barr RG. Establishing normal reference values in quantitative computed tomography of emphysema. J Thorac Imaging 2013;28:280-283.
50. Copley SJ, Giannarou S, Schmid VJ, Hansell DM, Wells AU, Yang GZ. Effect of aging on lung structure in vivo: Assessment with densitometric and fractal analysis of high-resolution computed tomography data. J Thorac Imaging 2012;27:366-371.